# Misonix to acquire Solsys Medical for approximately $97 million

Misonix, Inc. has entered into a definitive agreement to acquire Solsys Medical, LLC, a regenerative medical company, in an all-stock transaction valued at approximately $97 million. The combined entity is expected to generate over $80 million in annual revenue for fiscal 2020.

- Type: Acquisition
- Announced: 2019-05-02
- Where: Farmingdale, New York, United States
- Value: $97.0M
- Status: announced
- Products: minimally invasive therapeutic ultrasonic medical devices, advanced wound care product TheraSkin
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Misonix](https://endata.com/companies/28191.md) (acquirer)
- [Solsys Medical, LLC](https://endata.com/companies/39281.md) (target)

## Sources

- [globenewswire.com](https://www.globenewswire.com/news-release/2019/05/02/1815654/0/en/misonix-inc-enters-into-definitive-agreement-to-acquire-regenerative-medical-company-solsys-medical-for-approximately-97-million.html), 2019-05-02: "Misonix, Inc. (Nasdaq: MSON) (“Misonix”) a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it has entered into a definitive agreement with Solsys Medical, LLC (“Solsys”), a privately held regenerative medical company, to acqu"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.